tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NovaBridge presents dose expansion data from Phase 1b study of givastomig
PremiumThe FlyNovaBridge presents dose expansion data from Phase 1b study of givastomig
1M ago
NovaBridge Biosciences Files Nine-Month 2025 Results and Updates Investors on Strategic Transition
Premium
Company Announcements
NovaBridge Biosciences Files Nine-Month 2025 Results and Updates Investors on Strategic Transition
2M ago
NovaBridge Biosciences Announces Positive Phase 1 Data for Ragistomig at ESMO-IO
Premium
Company Announcements
NovaBridge Biosciences Announces Positive Phase 1 Data for Ragistomig at ESMO-IO
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100